Chronic Myeloid Leukemia Accelerated Phase (CML-AP, Ph+)
1 clinical trials · Condition
◉ Watch Chronic Myeloid Leukemia Accelerated Phase (CML-AP, Ph+)
| Record | Firm | Date |
|---|---|---|
| Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic Malignancies (NCT03414450) | EDDC (Experimental Drug Development Centre), A*STAR Research Entities | 2018-04-25 |
Track Chronic Myeloid Leukemia Accelerated Phase (CML-AP, Ph+) automatically
Every clearance here is in the API, with alerts when new ones post.